Industries

A pricing decision in pharma is not a pricing decision in CPG: the buyers, constraints, and evidence standards differ by sector. These articles apply causal experimentation to the decisions specific industries actually face, from EV launches to fleet offers to category resets, with the sector's own validation path spelled out.

• Why a Single Forecast Number Hides the Risk You're Actually Taking

  A point forecast leaves out the uncertainty and assumptions that determine a decision's downside.

• Where CPG Product Decisions Break Before They Ship

  A CPG innovation team needs evidence while a concept, package, or price can still change.

• Testing Healthcare Launch Decisions Before the Qualitative Study Starts

  A medtech or pharma team planning a device or support-program launch needs a research sequence matched to the claim and audience.

• How CPG Teams Test a Price Increase Before a Shelf Reset

  A revenue-growth or brand lead preparing for a shelf reset needs to evaluate a proposed SKU price, pack size, and competitive set.

• How inflation impacts different businesses

  A pricing leader deciding how to pass through cost increases needs to compare customer impact with contribution margin.

• How to Test Patient Messaging in a Regulated Environment

  A pharma brand team testing patient messages needs review before collection and again before final use.

• Testing EV Buyer Segments, Feature Trade-offs, and Price Tiers Before Automotive Launch Spend

  Automotive teams comparing EV features, prices, and messages need evidence before allocating capital.

• Payer Perception Research When You Cannot A/B Test

  Payer perception research can test responses to alternative value stories when a live formulary experiment is impractical.

• Nike Leads Conjointly's US Sneaker Tracker: Compare Funnel Transitions

  A brand strategist allocating sneaker marketing spend needs to distinguish brand tracking from sales and from intervention evidence.

• Research Methods for Hard to Reach Prescribers and Rare Disease Populations

  A commercial or medical affairs lead researching a rare disease or narrow specialty needs to assess what the available population can support.

• How CPG Teams Should Gate Packaging Redesigns Before Production

  A CPG team choosing a packaging redesign needs to assess communication and physical retail performance separately.

• How Government Communications Teams Can Pre-Test Public Messaging Before Launch

  A government communications team can compare draft messages before launch using appropriately designed human research or an optional modeled screen.

• Real Estate and Financial Services: Test Messaging Before It Ships

  Real estate and financial services involve long buyer journeys and consequential decisions.

• Source of Volume Analysis: Category Growth vs Brand Switching

  An innovation or category lead evaluating a listing needs to distinguish category expansion, switching from competitors, and losses to the brand's own line.

• Bayesian Computation in Finance: Modeling Risk as a Distribution, Not a Guess

  A financial-model buyer needs more than a point estimate of beta, loss, or option value: ask which uncertainty is quantified and which assumptions remain outside the calculation.

• What Promotion Mechanics Are Used in FMCG/CPG?

  A revenue growth management lead choosing the mechanic for next quarter's promo calendar decides which lever moves volume without training shoppers to wait for the next deal.

• Where Should the Next Wegmans Open? 7 Checks for a Bayesian Site-Selection Forecast

  A new-store forecast should separate observed evidence from assumptions before a retail real estate team commits build-out and lease capital or accepts the risk that a new…

• How to Run a Shelf Simulation Before a Retailer Meeting

  A category lead preparing for a retailer meeting needs to decide which shelf change to recommend and what evidence supports it.

• AustralianSuper Leads the Brand Tracker in Early 2026

  A super fund's marketing lead considering brand or product investment should distinguish market description from causal evidence.

• AustralianSuper Leads the Funnel, CommBank Leads on Perceived Support

  An Australian super fund's marketing or CX lead deciding between brand investment and service improvement needs to keep two studies separate.

• AI Research for Financial Services: Testing Client Decisions You Can't Survey

  Wealth-management, insurance, and retail-banking teams need to compare retention messages, product propositions, and price framing for specific clients.

• AI Panels for Luxury Brands: Testing Positioning Before It Ships

  A luxury brand leader choosing positioning, price framing, a category extension, or a retail concept needs evidence about a narrowly defined audience.

• AI Research for Pharma: Pressure-Test Positioning Before Launch

  A pharma launch lead needs to decide which positioning, advisory questions, patient-journey assumptions, and access arguments warrant further work.

• 8 Questions to Ask Before You Trust a Segment Estimate

  A quant researcher who owns a firm-characteristic return model has to choose every time a new segment shows up in the data: report one pooled coefficient for every sector, split…

• Automotive Research: Test EV Buyer Decisions Before Launch

  Automotive teams can use controlled behavioral experiments to compare EV propositions, pricing, launch messages, and dealership interventions before committing a model or…